CHM
Click for more information
4.55% 2.1¢ chimeric therapeutics limited

Ann: CORE NK Platform Phase 1 Clinical Data Presentation

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    07/03/22
    09:21
    Post #: 60022181
    Likes Created with Sketch. 32  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

NMT Neometals eyeing 80% stake in US-based precious metal waste recovery plant
right-arrow Created with Sketch.
ARU More, more, more: Arafura eyes another US$300M in funding for flagship
right-arrow Created with Sketch.
SS1 Sun Silver books specialty firm to enhance US solar panel silver paste grant
right-arrow Created with Sketch.
NEWS The Telstra twist - What the job cuts decision mean for investors?
right-arrow Created with Sketch.
PLY PlaySide to take gamers back to Westeros with new PC title
right-arrow Created with Sketch.
NEWS Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
-0.001(4.55%) 		Mkt cap ! $17.98M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $17.45K 819.5K

Buyers (Bids)

No. Vol. Price($)
13 1138038 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 140000 2
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
2.2¢ 		  Change
-0.001 ( 0.00 %)
Open High Low Volume
2.2¢ 2.2¢ 2.1¢ 486158
Last updated 12.42pm 28/05/2024 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.